GR3007396T3 - - Google Patents

Info

Publication number
GR3007396T3
GR3007396T3 GR920403219T GR920403219T GR3007396T3 GR 3007396 T3 GR3007396 T3 GR 3007396T3 GR 920403219 T GR920403219 T GR 920403219T GR 920403219 T GR920403219 T GR 920403219T GR 3007396 T3 GR3007396 T3 GR 3007396T3
Authority
GR
Greece
Prior art keywords
salt
combination
amine compound
anionic polymer
pharmaceutical solutions
Prior art date
Application number
GR920403219T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007396T3 publication Critical patent/GR3007396T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR920403219T 1989-09-21 1993-03-18 GR3007396T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24331089 1989-09-21

Publications (1)

Publication Number Publication Date
GR3007396T3 true GR3007396T3 (el) 1993-07-30

Family

ID=17101932

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920403219T GR3007396T3 (el) 1989-09-21 1993-03-18

Country Status (15)

Country Link
US (1) US6051223A (el)
EP (1) EP0419252B1 (el)
JP (1) JP2520975B2 (el)
KR (1) KR930008908B1 (el)
CN (1) CN1041799C (el)
AT (1) ATE86867T1 (el)
BR (1) BR9004692A (el)
CA (1) CA2025317C (el)
DE (1) DE69001110T2 (el)
DK (1) DK0419252T3 (el)
ES (1) ES2054263T3 (el)
FI (1) FI104953B (el)
GR (1) GR3007396T3 (el)
NO (1) NO904119L (el)
NZ (1) NZ235298A (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
CN101346471B (zh) * 2006-03-27 2016-01-06 农工大Tlo株式会社 三异戊二烯基酚化合物、三异戊二烯基酚化合物的制造方法和血栓溶解促进剂
AU2013274406B2 (en) * 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
CN103191054B (zh) * 2013-04-19 2015-05-27 范克 一种肝素钠封管注射液及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310133A2 (fr) * 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
JPS52145591A (en) * 1976-05-28 1977-12-03 Kanebo Ltd Stabilization of urokinase
JPS5467089A (en) * 1977-11-07 1979-05-30 Dainippon Pharmaceut Co Ltd Urokinase composition
JPS5568290A (en) * 1978-11-16 1980-05-22 Kanebo Ltd Stabilization of urokinase
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
JPS60158116A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60158117A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
WO1986005095A1 (en) * 1985-03-06 1986-09-12 Survival Technology, Inc. t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
JPH0669960B2 (ja) * 1985-11-22 1994-09-07 エーザイ株式会社 水溶性を増加したｔＰＡ含有医薬組成物
DE3687255T2 (de) * 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
JPS62292729A (ja) * 1986-06-12 1987-12-19 Toyobo Co Ltd ヒト子宮組織由来プラスミノ−ゲン活性化因子製剤
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH06226234A (ja) * 1993-02-01 1994-08-16 Shojiro Takeuchi 産業廃棄物の炭化処理方法
JPH06236332A (ja) * 1993-02-09 1994-08-23 Oki Electric Ind Co Ltd プログラムローディング装置
JPH06259221A (ja) * 1993-03-05 1994-09-16 Tokyo Electric Co Ltd 画面表示器を備えた情報処理装置
JPH06281326A (ja) * 1993-03-30 1994-10-07 Shibaura Eng Works Co Ltd 洗浄物の乾燥方法

Also Published As

Publication number Publication date
DE69001110T2 (de) 1993-06-24
FI904617A0 (fi) 1990-09-19
US6051223A (en) 2000-04-18
JP2520975B2 (ja) 1996-07-31
NO904119L (no) 1991-03-22
FI104953B (fi) 2000-05-15
JPH0418032A (ja) 1992-01-22
AU6246790A (en) 1991-03-28
AU619697B2 (en) 1992-01-30
EP0419252B1 (en) 1993-03-17
DE69001110D1 (de) 1993-04-22
CA2025317A1 (en) 1991-03-22
ES2054263T3 (es) 1994-08-01
DK0419252T3 (da) 1993-04-19
ATE86867T1 (de) 1993-04-15
CA2025317C (en) 1996-05-07
KR910005883A (ko) 1991-04-27
BR9004692A (pt) 1991-09-10
NO904119D0 (no) 1990-09-20
CN1041799C (zh) 1999-01-27
KR930008908B1 (ko) 1993-09-17
EP0419252A1 (en) 1991-03-27
NZ235298A (en) 1992-12-23
CN1050321A (zh) 1991-04-03

Similar Documents

Publication Publication Date Title
DE60036017T2 (de) Verfahren zur thrombolyse durch lokale behandlung mit reversibel inaktiviertem, angesäuertem plasmin
CA2203961A1 (en) Storage-stable fibrinogen preparations
AU1732288A (en) A process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
GR3007396T3 (el)
CH637992A5 (de) Verfahren zur herstellung eines komplexes aus streptokinase und einer leichten (b) plasmin-kettenfraktion mit einem aktiven serinprotease-zentrum.
EP0303236A3 (en) Lignosulfonate based pharmacologic agent with anti-thrombotic activity
DE3942141A1 (de) K2p pro-stabilisierung
FI91710B (fi) Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi
EP0458949B1 (de) Stabilisierung von k1k2p pro
FI98891B (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
KR890003403A (ko) 당뇨병의 합병증을 예방하거나 치료하기 위한 제제
EP0653212A4 (en) ANTITHROMBIN III COMPOSITION IN LIQUID FORM AND METHOD FOR STABILIZING IT.
MY104837A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
GR3007469T3 (el)